355 related articles for article (PubMed ID: 18852656)
1. Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation.
Borchhardt KA; Heinzl H; Mayerwöger E; Hörl WH; Haas M; Sunder-Plassmann G
Transplantation; 2008 Oct; 86(7):919-24. PubMed ID: 18852656
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism.
Serra AL; Schwarz AA; Wick FH; Marti HP; Wüthrich RP
Nephrol Dial Transplant; 2005 Jul; 20(7):1315-9. PubMed ID: 15941845
[TBL] [Abstract][Full Text] [Related]
3. The effect of cinacalcet on bone remodeling and renal function in transplant patients with persistent hyperparathyroidism.
Schwarz A; Merkel S; Leitolf H; Haller H
Transplantation; 2011 Mar; 91(5):560-5. PubMed ID: 21192318
[TBL] [Abstract][Full Text] [Related]
4. Cinacalcet de novo in persistent hypercalcemia after kidney transplantation secondary to hyperparathyroidism: long-term follow-up and effect of withdrawal.
Paschoalin RP; Torregrosa JV; Barros X; Durán CE; Campistol JM
Transplant Proc; 2012 Oct; 44(8):2376-8. PubMed ID: 23026597
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Use of Cinacalcet in Kidney Transplant Recipients With Hypercalcemic Secondary Hyperparathyroidism: A Single-Center Prospective Study.
Zavvos V; Fyssa L; Papasotiriou M; Papachristou E; Ntrinias T; Savvidaki E; Goumenos DS
Exp Clin Transplant; 2018 Jun; 16(3):287-293. PubMed ID: 29108515
[TBL] [Abstract][Full Text] [Related]
6. Cinacalcet treatment for stable kidney transplantation patients with hypercalcemia due to persistent secondary hyperparathyroidism: a long-term follow-up.
Paschoalin RP; Torregrosa JV; Sánchez-Escuredo A; Barros X; Durán CE; Campistol JM
Transplant Proc; 2012 Nov; 44(9):2588-9. PubMed ID: 23146463
[TBL] [Abstract][Full Text] [Related]
7. Normalization of lithium-induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride.
Sloand JA; Shelly MA
Am J Kidney Dis; 2006 Nov; 48(5):832-7. PubMed ID: 17060004
[TBL] [Abstract][Full Text] [Related]
8. Phosphatemic effect of cinacalcet in kidney transplant recipients with persistent hyperparathyroidism.
Serra AL; Wuhrmann C; Wüthrich RP
Am J Kidney Dis; 2008 Dec; 52(6):1151-7. PubMed ID: 18950915
[TBL] [Abstract][Full Text] [Related]
9. Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism.
Szwarc I; Argilés A; Garrigue V; Delmas S; Chong G; Deleuze S; Mourad G
Transplantation; 2006 Sep; 82(5):675-80. PubMed ID: 16969292
[TBL] [Abstract][Full Text] [Related]
10. Treatment of persistent hyperparathyroidism in renal transplant patients with cinacalcet improves control of blood pressure.
Carrasco FR; Pérez-Flores I; Calvo N; Ridao N; Sánchez A; Barrientos
Transplant Proc; 2009; 41(6):2385-7. PubMed ID: 19715927
[TBL] [Abstract][Full Text] [Related]
11. Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients.
Serra AL; Savoca R; Huber AR; Hepp U; Delsignore A; Hersberger M; Wüthrich RP
Nephrol Dial Transplant; 2007 Feb; 22(2):577-83. PubMed ID: 17005527
[TBL] [Abstract][Full Text] [Related]
12. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism.
Kruse AE; Eisenberger U; Frey FJ; Mohaupt MG
Nephrol Dial Transplant; 2005 Jul; 20(7):1311-4. PubMed ID: 15941846
[TBL] [Abstract][Full Text] [Related]
13. Hypercalcemia due to resistant hyperparathyroidism in renal transplant patients treated with the calcimimetic agent cinacalcet.
Apostolou T; Kollia K; Damianou L; Kaitsioti H; Kotsiev V; Dracopoulos S; Vougas V; Hadjiconstantinou V
Transplant Proc; 2006 Dec; 38(10):3514-6. PubMed ID: 17175318
[TBL] [Abstract][Full Text] [Related]
14. Evolution of secondary hyperparathyroidism after kidney transplantation in patients receiving cinacalcet on dialysis.
Torregrosa JV; Bergua C; Martinez de Osaba MJ; Oppenheimer F; Campistol JM
Transplant Proc; 2009; 41(6):2396-8. PubMed ID: 19715931
[TBL] [Abstract][Full Text] [Related]
15. Treatment with cinacalcet of secondary hyperparathyroidism after renal transplantation.
Gómez Marqués G; Obrador Mulet A; Vilar Gimeno A; Pascual Felip MJ; Alarcón Zurita A; Molina Guasch M; Uriol Rivera M; Munar Vila MA; Losada González P
Transplant Proc; 2009; 41(6):2139-43. PubMed ID: 19715856
[TBL] [Abstract][Full Text] [Related]
16. Cinacalcet for the treatment of hypercalcemia in renal transplanted patients with secondary hyperparathyroidism.
Bergua C; Torregrosa JV; Cofán F; Oppenheimer F
Transplant Proc; 2007 Sep; 39(7):2254-5. PubMed ID: 17889155
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cinacalcet HCl treatment after kidney transplantation.
Copley JB; Germain M; Stern L; Pankewycz O; Katznelson S; Shah T; Wang O; Turner SA; Sprague SM
Transplant Proc; 2010 Sep; 42(7):2503-8. PubMed ID: 20832532
[TBL] [Abstract][Full Text] [Related]
18. Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism.
Kruse AE; Eisenberger U; Frey FJ; Mohaupt MG
Nephrol Dial Transplant; 2007 Aug; 22(8):2362-5. PubMed ID: 17510094
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hyperparathyroidism with cinacalcet in kidney transplant recipients.
Borstnar S; Erzen B; Gmeiner Stopar T; Kocjan T; Arnol M; Kandus A; Kovac D
Transplant Proc; 2010 Dec; 42(10):4078-82. PubMed ID: 21168632
[TBL] [Abstract][Full Text] [Related]
20. Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism.
Bergua C; Torregrosa JV; Fuster D; Gutierrez-Dalmau A; Oppenheimer F; Campistol JM
Transplantation; 2008 Aug; 86(3):413-7. PubMed ID: 18698244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
